HH
HALO icon

HWG Holdings’s Halozyme HALO Stock Holding History

HWG Holdings’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-17,646
Closed -$306K – 39
2015
Q4 		$306K Buy
+17,646
New +$281K 0.31% 23
2014
Q1 		– Sell
-189,694
Closed -$2.84M – 46
2013
Q4 		$2.84M Buy
+189,694
New +$2.44M 1.83% 15

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

HWG Holdings's HALO Position: Q1 2016 in Review

HWG Holdings sold out of Halozyme (HALO) in Q1 2016, closing a stake of 17,646 shares — an estimated $306K sold.

HWG Holdings first reported a position in HALO in Q4 2013 and held it in 2 quarters. The position peaked at $2.84M in Q4 2013. 161 funds tracked by Wall St. Rank hold HALO as of Q1 2016.

  • HWG Holdings reported no remaining Halozyme position as of Q1 2016 after selling out during the quarter.
  • HWG Holdings sold 17,646 Halozyme shares in Q1 2016, an estimated $306K.
  • HWG Holdings first reported a position in Halozyme in Q4 2013 and held it in 2 quarters.
  • HWG Holdings's Halozyme position peaked at $2.84M in Q4 2013.
  • 161 funds tracked by Wall St. Rank held Halozyme as of Q1 2016.

Based on HWG Holdings's 13F filing for Q1 2016, filed 6 May 2016.